ARCHIVES

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Plant-Based Diet Associated With Improved Survival

April 25, 2008

ASCO Endorses Guideline for Molecular Testing

October 17, 2014

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994